• US Oncology Holdings highlighted research already presented at ASCO 2026 on APP-led new consult models in benign hematology at community practices.
• The analysis found the model shortened waits for initial appointments, increased practice capacity, and shifted more consult volume from physicians to APPs.
• The findings support a scalable operating approach for community oncology groups facing access constraints, with potential to expand patient throughput without disrupting care continuity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. US Oncology Holdings Inc. published the original content used to generate this news brief on May 29, 2026, and is solely responsible for the information contained therein.